Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy

Technology in Cancer Research & Treatment
Satoshi FunayamaMasayuki Takeda

Abstract

To evaluate the safety and efficacy of stereotactic body radiation therapy for primary lesion of renal cell carcinoma with long-term and regular follow-up of tumor size and renal function. This prospective study included 13 patients treated with stereotactic body radiation therapy for primary lesion of stage I renal cell carcinoma between August 2007 and June 2016 in our institution. Diagnosis of renal cell carcinoma was made by 2 radiologists using computed tomography or magnetic resonance imaging. A dosage of 60 Gy in 10 fractions or 70 Gy in 10 fractions was prescribed. The higher dose was selected if dose constraints were satisfied. Tumor response on imaging examination, local progression-free rate, overall survival, and toxicity were assessed. The mean follow-up period was 48.3 months (range: 11-108 months). The tumors showed very slow but continuous response during long-term follow-up. Three cases (23.1%) showed transient progression during the short follow-up. The mean duration until the day on which partial response was confirmed among the partial or complete response cases was 22.6 months (95% confidence interval, 15.3-30.0 months). Local progression-free rate was 92.3% for 3 years and overall survival rate 91.7% for 2...Continue Reading

References

Oct 31, 2002·Journal of Neurosurgery·Berndt WowraAlfons Hofstetter
Dec 4, 2004·American Journal of Clinical Oncology·Jonathan J BeitlerGil Lederman
Jun 24, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter J WersällChrister Svedman
Oct 19, 2006·Journal of Neurosurgery·Takashi ShutoHisato Nagano
Jan 8, 2008·Surgical Innovation·Lee E PonskyAndrew C Novick
Apr 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Takuma NomiyaHirohiko Tsujii
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Aug 18, 2009·The Journal of Urology·Steven C CampbellUNKNOWN Practice Guidelines Committee of the American Urological Association
Aug 5, 2014·Current Opinion in Supportive and Palliative Care·Patrick CheungGeorg A Bjarnason
Aug 19, 2014·The Journal of Urology·Michael StaehlerAlexander Muacevic
Jan 27, 2015·European Urology·Borje LjungbergAxel Bex
Jul 5, 2015·Japanese Journal of Clinical Oncology·Megumi HoriUNKNOWN Japan Cancer Surveillance Research Group
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
May 28, 2016·Radiation Oncology·Takaya YamamotoKeiichi Jingu
Jun 8, 2017·International Journal of Radiation Oncology, Biology, Physics·Chiachien Jake WangRaquibul Hannan
Dec 20, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Elizabeth DudnikUNKNOWN Israel Lung Cancer Group

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Software Mentioned

survival
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.